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S pinal metastasis occurs in 30-60  of patients with a malignant tumor [1-3].  Metastatic epi-
dural spinal cord compression (MESCC) is a common 
complication in patients with malignant tumors occur-
ring in 5-14  of all cases [4-7].  There are a variety 
of options for the treatment of MESCC.  Some 
patients are treated nonsurgically by radiotherapy or 
chemotherapy,  while others undergo surgical treat-
ments such as posterior decompression with or without 
instrumentation or total en bloc spondylectomy [8-11].  
Several authors have reported that radiotherapy is as 
eﬀective as decompressive surgery in preserving neu-
rological function and pain control [4,12-14].  
However,  decompressive surgery was shown to be 
superior to radiotherapy in preserving neurological 
function [15,16].  Although the goals of surgery for 
MESCC are to improve the patientʼs prognosis and 
quality of life,  it is diﬃcult to decide the proper time 
to perform the surgery.  In this study,  we analyzed 
MESCC patients who underwent surgery,  and we 
determined the prognostic factors for postoperative 
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Metastatic epidural spinal cord compression (MESCC) is a common complication in patients with a 
malignant tumor,  but it is diﬃcult to decide the proper time to perform the necessary surgery.  Here 
we analyzed the prognostic factors for postoperative walking ability.  We retrospectively reviewed the 
cases of 112 MESCC patients treated surgically at our institute and divided them into ambulatory (n＝
88) and non-ambulatory (n＝24) groups based on their American Spinal Injury Association (ASIA) 
Impairment Scale grades at the ﬁnal follow-up.  We also classiﬁed the patients preoperatively using the 
revised Tokuhashi score.  We assessed the correlation between preoperative or intraoperative factors 
and postoperative walking ability in both groups.  Of the 10 patients classiﬁed preoperatively as grade 
A or B,  2 (20 ) were ambulatory at the ﬁnal follow-up.  Of the 102 patients classiﬁed preoperatively as 
grade C,  D or E,  86 (84 ) were ambulatory at the ﬁnal follow-up (p＜0.001).  There were no signiﬁ-
cant diﬀerences between the groups in the average total Tokuhashi score.  Our analysis revealed that 
the severity of paralysis signiﬁcantly aﬀects neurological recovery in patients with MESCC.  Patients 
with MESCC should receive surgery before the preoperative ASIA Impairment Scale grade falls below 
grade C.
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walking ability.
Patients and Methods
　 This study was approved by the ethical review 
board of our hospital (ID 1604-503).  From 1987 to 
2014,  112 consecutive patients with MESCC (73 men 
and 39 women) underwent surgery at our hospital.  
The average age was 61.5 years (range 14-83 years).  
The average period from the onset of symptoms (local 
back pain,  radicular pain and neurological deﬁcit) to 
surgery was 99.4 days (range 1-1100 days).  The aver-
age follow-up time after surgery was 17.0 months 
(range 0.5-84 months) (Table 1).
　 Using the American Spinal Injury Association 
(ASIA) Impairment Scale [17],  we classiﬁed these 
112 patients preoperatively as grade A in 2 patients,  
B in 8,  C in 59,  D in 36 and E in 7 patients.  The 
ASIA Impairment Scale grades are deﬁned as fol-
lows: grade A,  no sensory or motor function is pre-
served in the sacral segments; grade B,  sensory but 
not motor function is preserved below the neurological 
level and includes the sacral segments; grade C,  
motor function is preserved below the neurological 
level,  and more than half of key muscles below the 
neurological level have a muscle grade＜3; grade D,  
motor function is preserved below the neurological 
level,  and at least half of key muscles below the neu-
rological level have a muscle grade 3; grade E,  
sensory and motor function is normal.
　 The surgical indications are neurological deﬁcit,  
severe pain and possibility of spinal vertebrae col-
lapse.  We chose a posterior procedure to achieve 
decompression of the spinal cord.  We performed 
instrumentation surgery if the patient had spinal insta-
bility.  Seven patients underwent decompression sur-
gery alone,  and 87 patients underwent decompression 
surgery with posterior fusion.  Five patients under-
went both anterior and posterior approaches,  and 11 
underwent total en bloc spondylectomies.
　 We classiﬁed the 112 patients preoperatively using 
the revised Tokuhashi score [18].  There were 57 
patients whose total Tokuhashi scores were 0-8,  52 
whose total scores were 9-11,  and 13 whose total 
scores were 12-15.  The revised Tokuhashi score con-
sists of 6 items thought to aﬀect the outcome (general 
condition,  number of bone metastases other than spi-
nal metastases,  number of spinal metastases,  type of 
primary lesion,  presence or absence of metastases to 
major organs,  and state of paralysis).  The survival 
period is predicted to be 6 months when the total 
score is 0-8,  6 months when the total score is 9-11,  
and 1 year when the total score is 12.
　 The primary tumors in these patients included lung 
(n＝25),  prostate (n＝13),  kidney (n＝12),  breast 
(n＝12) and thyroid (n＝10) (Table 2).  Sixteen 
responsible lesions were located in cervical vertebrae,  
76 in thoracic vertebrae and 20 in lumbar vertebrae.  
Of the 112 patients,  16 (14 ) had multiple spinal 
compression lesions.
　 We performed a retrospective review and divided 
the patients into 2 groups based on their ASIA 
Impairment Scale grades at the ﬁnal follow-up.  There 
were 88 patients (58 men and 30 women) in the ambu-
latory group and 24 patients (15 men and 9 women) in 
the non-ambulatory group.  The average age was 60.6 
years (14-83 years) in the ambulatory group and 64.6 
years (40-78 years) in the non-ambulatory group.  The 
types of primary tumors found in the ambulatory 
group were lung (n＝21),  breast (n＝10),  prostate 
(n＝10),  thyroid (n＝8) and kidney (n＝6).  The 
patients in the non-ambulatory group had kidney 
(n＝6),  lung (n＝4),  prostate (n＝3),  thyroid (n＝2) 
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Table 1　 Patients characteristics (n＝112)
Age＊ 61.5 (14-83) years
Sex (male/female) 73/39 patients
The time from the onset until
operation＊ 99.4 (1-1,100) days
Follow-up time after surgery＊ 17.0 (0.5-84) months
＊average (range)
Table 2　 Sites of primary tumors
Primary tumors Ambulatory Non-ambulatory Total
Lung 21  4 25
Prostate 10  3 13
Kidney  6  6 12
Breast 10  2 12
Thyroid  8  2 10
Gastric  3  1 4
Rectum  2  1 3
Liver  2  1 3
Osteosarcoma  3  0 3
Others 21  3 24
Unclear  2  1 3
Total 88 24 112
and breast (n＝2) tumors (Table 2).
　 The ambulatory group had 15 lesions located in 
cervical vertebrae,  55 in thoracic vertebrae and 18 in 
lumbar vertebrae,  whereas one lesion was located in 
cervical vertebrae,  21 in thoracic vertebrae and 2 in 
lumbar vertebrae in the non-ambulatory group.  As for 
the preoperative impairment scale grades,  there were 
2 patients with grade B impairment,  44 with grade C,  
35 with grade D and 7 with grade E in the ambulatory 
group.  In the non-ambulatory group,  there were 2 
patients with grade A impairment,  6 with grade B,  15 
with grade C and one with grade D.  Grade C was most 
prevalent in both groups.  As for the revised Tokuhashi 
score,  there were 44 patients whose total scores were 
0-8,  33 whose total scores were 9-11 and 11 whose 
total scores were 12-15 in the ambulatory group.  In 
the non-ambulatory group there were 13 patients 
whose total scores were 0-8,  9 whose total scores 
were 9-11,  and 2 whose total scores were 12-15.
　 We assessed the correlations between preoperative 
or intraoperative factors and the patientsʼ postopera-
tive walking ability in both groups,  using the Mann-
Whitney U-test and Fisherʼs exact probability test.  We 
regarded a value of p＜0.05 as signiﬁcant.
Results
　 Of the 10 patients classiﬁed preoperatively as 
grade A or B,  2 (20 ) were ambulatory at the ﬁnal 
follow-up (Table 3).  In contrast,  of the 102 patients 
classiﬁed preoperatively as grade C,  D or E,  86 
(84 ) were ambulatory at the ﬁnal follow-up (p＜
0.001).  The probability of a patient being able to walk 
after surgery was 0  for those with a preoperative 
impairment scale grade of A,  25  for grade B,  75  
for grade C,  97  for grade D and 100  for grade E 
(Fig. 1).
　 The average amount of intraoperative bleeding was 
960 ml (range 20-3,420 ml) in the ambulatory group 
and 1,230 ml (range 230-3,090 ml) in the non-ambula-
tory group.  The average length of surgery was 199 min 
(range 60-975 min) in the ambulatory group and 259 min 
(range 100-685 min) in the non-ambulatory group.  
There was no signiﬁcant diﬀerence between the groups 
in bleeding (p＝0.35) or duration of surgery (p＝
0.78).
　 The rates of improving by one grade at the ﬁnal 
follow-up on the ASIA Impairment Scale were 63  
(55 of 88 patients) in the ambulatory group and 25  (6 
of 24 patients) in the non-ambulatory group (Table 4).  
The average total Tokuhashi scores were 8.4 points in 
the ambulatory group and 7.8 in the non-ambulatory 
group.  There were no signiﬁcant diﬀerences between 
the 2 groups in the average total Tokuhashi score 
(p＝0.35) or the average score for each of the 5 mea-
sured Tokuhashi parameters,  except for the state of 
paralysis.  The average survival period was 12 months 
in both groups.
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Table 3　 ASIA impairment scale grade at ﬁnal follow-up based on 
preoperative ASIA impairment scale grade






(grade A ,B ,C)
grade (A ,B) 2pts 8pts ＊p＜0.001 10
A  0  2 2
B  2  6 8
grade (C ,D ,E) 86 16 102
C 44 15 59
D 35  1 36
E  7  0 7
Total 88 24 112
ASIA,  American Spinal Injury Association; Ambulatory group,  ASIA 
impairment score grade D and E at the ﬁnal follow-up; Non-Ambu-
latory group,  ASIA impairment score grade A, B and C at the ﬁnal 



























Fig. 1　 Probability of being ambulatory after surgery depending 
on the preoperative ASIA impairment score.  A severe preoperative 
ASIA impairment score was observed to reduce the probability of 
being ambulatory.  ASIA,  American Spinal Injury Association.
Discussion
　 Our ﬁndings revealed that the severity of the pre-
operative paralysis greatly aﬀected the ﬁnal walking 
ability in MESCC patients.  Patients with MESCC 
should receive spinal surgery before their ASIA 
Impairment Scale grade falls below grade C.  In our 
study,  10 patients had preoperative impairment scale 
grades of A or B,  and 2 of these patients (20 ) were 
ambulatory by the ﬁnal follow-up.
　 We graded 102 patients as C,  D or E,  and 86 
(84 ) recovered their ability to walk.  Several 
authors reported that the level of preoperative paral-
ysis was associated with postoperative ambulation 
[4-7,14,16,19-25].  Helweg-Larsen et al.  reported 
that ambulatory function before surgery was the main 
determinant for postoperative gait function [16].  
Chaichana et al.  also showed that the preoperative 
ability to walk was associated with ambulatory status 
at the time of the last follow-up [6].
　 In the present study,  the rates of improving by at 
least one grade on the ASIA Impairment Scale at the 
ﬁnal follow-up were 25  in the non-ambulatory group,  
63  in the ambulatory group,  and 54  for all 
patients.  Several groups showed that the improve-
ment rate was worse for patients who were non-ambu-
latory before surgery compared to those who were 
ambulatory [25-27].  Hirabayashi et al.  reported a 
39  (9 of 23 patients) improvement rate of at least 
one grade on the Frankel scale for patients in their 
non-ambulatory group,  89  (31 of 35 patients) in the 
ambulatory group and 69  (40 of 58 patients) overall 
[26].  Chong et al.  reported improvement rates of at 
least one Frankel grade in 11  (2 of 19) of preopera-
tive non-ambulatory patients,  43  (19 of 44) of ambu-
latory patients with a Frankel grade less than E,  and 
33  (21 of 63) of all patients with a Frankel grade 
less than E [25].
　 Other than the paralysis parameter,  our results 
showed no association between postoperative ambula-
tory status and Tokuhashi score or type of primary 
tumor.  Several research groups have reported rela-
tionships between the preoperative Tokuhashi score 
and postoperative ambulatory function or survival 
[7,22].  Park et al.  showed that the preoperative 
Tokuhashi score was signiﬁcantly associated with lon-
ger overall survival,  but it was not prognostic of post-
operative ambulation [7].  Moon et al.  demonstrated 
that the Tokuhashi scoring system was not a signiﬁ-
cant prognostic predictor for postoperative ambulatory 
function or survival [22].
　 Our present ﬁndings suggest that the average 
intraoperative blood loss and operation time are not 
associated with postoperative ambulatory function.  
Few studies have demonstrated any correlation between 
average intraoperative blood loss or operation time and 
postoperative ambulatory ability,  but several authors 
described other prognostic factors for postoperative 
ambulatory function in patients with spinal metastasis 
[6,7,22,25].
　 The limitations of this study include the short fol-
low-up period after surgery and the exclusion of a 
discussion on whether radiotherapy or chemotherapy 
was performed in the patients.
　 In conclusion,  our analysis of 112 consecutive 
patients with MESCC showed that the severity of 
their paralysis signiﬁcantly aﬀected their neurological 
recovery.  Patients with MESCC should undergo sur-
gery before the preoperative ASIA Impairment Scale 
grade falls below grade C.
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